Dr. Michael Dempsey

Medical Director, Johns Hopkins Diabetes Center at Suburban Hospital

GLG News by Dr. Michael Dempsey, Medical Director

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Non-glycemic benefits of Rosigliatazone: too little to late?

July 10, 2006

Analysis of:Rosiglitazone May Delay Progression of Severe Diabetic Retinopathy | www.ophthalmologytimes.com

Reduction of proliferative rentinopathy in patients with Diabetes by Rosigliatzone.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS